stomach pain low grade fever

This item was filled under [ Most Popular ]

ViiV Healthcare Presents New Data from HIV/AIDS Portfolio Demonstrating Research Advances and Commitment to Patient …
At the 17th Conference on Retroviruses and Opportunistic Infections , ViiV Healthcare presented new data across its broad range of investigational and current medicines for the treatment of HIV/AIDS.  Highlighted data at the conference included an oral presentation on the investigational integrase inhibitor, S/GSK1349572, as well as data presentations on SELZENTRY® and EPZICOM® . Â
Hepatitis

Be Sociable, Share!
Tags:
You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.



#